Influenza A virus impairs control of mycobacterium tuberculosis coinfection through a type i interferon receptor-dependent pathway

Journal of Infectious Diseases

Volumn 209, Issue 2, 2014, Pages 270-274

  Redford, Paul S ^a   Mayer Barber, Katrin D ^c   McNab, Finlay W ^a   Stavropoulos, Evangelos ^a   Wack, Andreas ^a   Sher, Alan ^c   O'Garra, Anne ^a,b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Co infection; Influenza; Interferon; Mycobacterium tuberculosis; Tuberculosis; Type I IFN

Indexed keywords

INTERFERON RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; MIXED INFECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TUBERCULOSIS;

EID: 84890098871     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit424     Document Type: Article

References (15)

1. Nunn P, Falzon D.World Health Organization (WHO) information on tuberculosis and pandemic influenza A (H1N1). Geneva, Switzerland: WHO Press, 2009
2. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: Implications for pandemic preparedness. Lancet Infect Dis 2006; 6:303-12
3. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004; 172:7603-9
4. Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008; 205:323-9
5. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009; 119:1910-20
6. Small CL, Shaler CR, McCormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 2010; 184: 2048-56
7. Oei W, Nishiura H. The relationship between tuberculosis and influenza death during the influenza (H1N1) pandemic from 1918-19. Comput Math Methods Med 2012; 2012:124861
8. Volkert M, Pierce C, Horsfall FL, Dubos RJ. The enhancing effect of concurrent infection with pneumotropic viruses on pulmonary tuberculosis in mice. J Exp Med 1947; 86:203-14
9. Wack A, Openshaw P, O'Garra A. Contribution of cytokines to pathology and protection in virus infection. Curr Opin Virol 2011; 1:184-95
10. Liu W, Li ZD, Tang F, et al. Mixed infections of pandemic H1N1 and seasonal H3N2 viruses in 1 outbreak. Clin Infect Dis 2010; 50:1359-65
11. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol 2013; 31:475-527
12. Manca C, Tsenova L, Bergtold A, et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-Alpha /beta. Proc Natl Acad Sci U S A 2001; 98:5752-7
13. Mayer-Barber KD, Andrade BB, Barber DL, et al. Innate and adaptive interferons suppress IL-1-Alpha and IL-1-beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 2011; 35:1023-34
14. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466:973-7
15. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. Induction of IFN-Alpha/beta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med 2010; 207:327-37